Literature DB >> 570667

Twin study of multiple sclerosis: an epidemiologic inquiry.

A R Bobowick, J F Kurtzke, J A Brody, Z Hrubec, M Gillespie.   

Abstract

The National Research Council Twin Registry comprises 16,000 pairs of white male twins, both members of which had been in military service, mainly in World War II. All their available military and Veterans Administration records and their responses to a 1965 to 1970 NRC questionnaire have been coded as to disease. Upon review we found 16 cases of multiple sclerosis (MS) among 15 pairs of twins, for an age-specific prevalence rate of 51 per 100,000 veterans aged 43 to 53--about half the expected frequency. Of the 15 sets, three sets refused cooperation and three were unavailable for study. Nine sets were examined and interviewed together with the mother. One of five monozygotic twin pairs was concordant for MS and in another the co-twin of an MS case had had a solitary episode of retrobulbar neuritis; all others were discordant. There were more definable environmental events (as noted below) among the affected twins than among the unaffected co-twins. The greatest excess was within the 20 years before onset. Summing events across the four 5-year periods before onset, among the 10 MS versus the eight not-MS individuals, there were 5:1 instances of trauma, 8:2 or operation, 7:1 of ether anesthesia, 7:1 of allergy, 10:5 of infection, and 9:0 of animal exposure. Summing these same events within each 5-year period, the MS:control ratios were 9:1, 10:2, 12:3, and 15:4, respectively, for 0 to 4, 5 to 9, 10 to 14, and 15 to 19 years before onset.

Entities:  

Mesh:

Year:  1978        PMID: 570667     DOI: 10.1212/wnl.28.10.978

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Twin concordance and sibling recurrence rates in multiple sclerosis.

Authors:  C J Willer; D A Dyment; N J Risch; A D Sadovnick; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  Uses and limitations of twin studies.

Authors:  S Bundey
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  British Isles survey of multiple sclerosis in twins: MRI.

Authors:  J W Thorpe; C J Mumford; D A Compston; B E Kendall; D G MacManus; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  Magnetic resonance imaging studies in multiple sclerosis twins.

Authors:  B M Uitdehaag; C H Polman; J Valk; J C Koetsier; C J Lucas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

Review 5.  The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.

Authors:  K C O'Connor; A Bar-Or; D A Hafler
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

6.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

7.  How multiple sclerosis is related to animal illness, stress and diabetes.

Authors:  S A Warren; K G Warren; S Greenhill; M Paterson
Journal:  Can Med Assoc J       Date:  1982-02-15       Impact factor: 8.262

Review 8.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 9.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

10.  Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.

Authors:  Mehrdad Sadeghi Haj; Abbas Nikravesh; Majid Pahlevan Kakhki; Nahid Rakhshi
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.